Understanding the landscape of carbapenemase-producing organisms (CPOs), and spotlighting opportunities for control in England
Authors:
Open Access
- 12 August 2025
- journal article
- review article
- Published by Elsevier in Infection Prevention in Practice
- Vol. 7 (4) , 100480
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Carbapenemase-producing Enterobacteriaceae in Europe: assessment by national experts from 38 countries, May 2015Eurosurveillance, 2015
- Managing a nosocomial outbreak of carbapenem‐resistant Klebsiella pneumoniae: an early Australian hospital experienceInternal Medicine Journal, 2015
- Detection of NDM-1 carbapenemase-producing Acinetobacter calcoaceticus and Acinetobacter junii in environmental samples from livestock farmsJournal of Antimicrobial Chemotherapy, 2014
- Carbapenemase-producing Enterobacteriaceae in Europe: a survey among national experts from 39 countries, February 2013Eurosurveillance, 2013
- The role of international travel in the worldwide spread of multiresistant EnterobacteriaceaeJournal of Antimicrobial Chemotherapy, 2012
- Containment of a Country-wide Outbreak of Carbapenem-Resistant Klebsiella pneumoniae in Israeli Hospitals via a Nationally Implemented InterventionClinical Infectious Diseases, 2011
- Attributable Mortality Rate for Carbapenem-Resistant Klebsiella pneumoniae BacteremiaInfection Control & Hospital Epidemiology, 2009
- Isolation of Imipenem-Resistant Enterobacter Species: Emergence of KPC-2 Carbapenemase, Molecular Characterization, Epidemiology, and OutcomesAntimicrobial Agents and Chemotherapy, 2008
- Management of multidrug-resistant organisms in health care settings, 2006American Journal of Infection Control, 2007
- The Epidemiological Profile of Infections with Multidrug-Resistant Pseudomonas aeruginosa and Acinetobacter SpeciesClinical Infectious Diseases, 2006